The first 10 drugs to make the cut for negotiations were announced in September, with three on the list from Johnson & Johnson, and one each for Bristol Myers Squibb, Merck & Co, Novartis, Lilly, AstraZeneca, Novo Nordisk and Amgen
Insurance coverage: Neither compound is covered for weight loss through traditional insurance, as both are research peptides
3 If youre switching from injectable Mounjaro or Wegovy Both pills are options for maintaining weight loss after an injectable course
These include pancreatitis, gastroparesis, gallbladder and biliary disease, and, in select cases, acute kidney injury related to dehydration
The STEP trials, for instance, combined semaglutide with lifestyle intervention including dietary counselling aimed at a 500-600 calorie deficit
& Norris, K